J&J’s Ethicon unit in April suspended sales and distribution of the devices while their role in treating symptomatic fibroid disease is reviewed by the U.S. The FDA had advised doctors not to use the devices pending further review. On Thursday, J&J will take the further step of reaching out to …

READ FULL ARTICLE Curated publisher From Reuters